Stocks
Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -403.2% | -174.1% | -101.0% | -109.0% | -24.1% | -16.6% | ||
| Changes by years, y/y, % | +613pp | +229pp | +73pp | -8pp | +85pp | -52.7% | |||
Alnylam Pharmaceuticals. Net margin, %
Alnylam Pharmaceuticals. Net margin, changes, pp
Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net margin, % | ? | -54.5% | -86.6% | 19.7% | -31.4% | -13.3% | -16.6% | |
| Changes by years, y/y, % | +58pp | +37pp | +173pp | +31pp | +41pp | |||
| Changes by quarters, q/q, % | +7pp | -32pp | +106pp | -51pp | +18pp | |||
